PLUMB PHARMACEUTICALS, INC

Biotech · Private

Extended-release naltrexone formulation using proprietary Advanced Quantload technology for opioid addiction maintenance therapy

Grants
$503K
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
1 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Refining a 3-month release buprenorphine, advancing a drug delivery platform$224,850
Federal grantDepartment of Health and Human Services · Phase I · A 3-month Release Naltrexone for Addiction Treatment$202,563
Federal grantDepartment of Health and Human Services · Phase I · A 3-month Release Naltrexone for Addiction Treatment$55,000
Federal grantDepartment of Health and Human Services · Phase I · A 3-month Release Naltrexone for Addiction Treatment$20,186
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2949Vitanova Biomedical, Inc.—$8.0M
2950OnCusp Therapeutics——
2951COVALABIO INC.——
2952PLUMB PHARMACEUTICALS, INC——
2953Stem Cell Development Fund, LLC—$2.8M
2954TISSUEFORM, INC.——
2955Diasome Pharmaceuticals, Inc.—$50M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 4
  • Liposome Loadingapplication
  • Liposome Loadinggranted
  • Liposome Loading With Polyanionsapplication
  • Liposome Loading With Polyanionsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.